Litcius/Paper detail

T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants

Thi H. O. Nguyen, Carolyn A. Cohen, Louise C. Rowntree, Maireid Bull, Asmaa Hachim, Katherine Kedzierska, Sophie A. Valkenburg

2021Frontiers in Medicine28 citationsDOIOpen Access PDF

Abstract

T cell responses are a key cornerstone to viral immunity to drive high-quality antibody responses, establishing memory for recall and for viral clearance. Inefficient recruitment of T cell responses plays a role in the development of severe COVID-19 and is also represented by reduced cellular responses in men, children, and diversity compared with other epitope-specific subsets and available T cell receptor diversity. SARS-CoV-2-specific T cell responses are elicited by multiple vaccine formats and augmented by prior infection for hybrid immunity. Epitope conservation is relatively well-maintained leading to T cell crossreactivity for variants of concern that have diminished serological responses.

Topics & Concepts

EpitopeBiologyImmunologyVirologyImmunityT cellVaccinationAntibodyImmune systemSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Antibody responseMemory T cellSerologyMedicinePathologyInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCOVID-19 Clinical Research Studies